SCHEMBL12352136

SCHEMBL12352136

O=c1oc(-c2ccc(-c3nc4nccnc4c(=O)o3)s2)nc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
F2 P00734 4/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
HPGD P15428 3/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 2/20 0.53
ELANE P08246 3/20 0.50
C1R P00736 6/20 0.48
PLG P00747 1/20 0.48
KLK1 P06870 1/20 0.48
PRSS1 P07477 1/20 0.48
C1S P09871 1/20 0.48
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
KDM4E B2RXH2 4/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ATM Q13315 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
POLB P06746 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2544499 0.85 ALDH1A1 (0.69) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL13701129 0.84 ALDH1A1 (0.68) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL13701134 0.80 ELANE (0.64) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL12352131 0.74 HPGD (0.56) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL13701105 0.74 ALDH1A1 (0.58) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL13701131 0.73 ALDH1A1 (0.57) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL272287 0.72 ELANE (0.81) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL5433311 0.72 ALDH1A1 (0.59) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL13701135 0.72 ALDH1A1 (0.56) ALDH1A1F2SMN1; SMN2HPGDKMT2A
SCHEMBL20707142 0.72 ALDH1A1 (0.52) ALDH1A1F2SMN1; SMN2HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8541488-B2 Formed resin article and polymer film FUJIFILM CORPORATION (JP) 2013-09-24 US disclosed
US-8541488-B2 Formed resin article and polymer film FUJIFILM CORPORATION (JP) 2013-09-24 US disclosed
US-20110186791-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2011-08-04 US disclosed
US-20110186791-A1 ULTRAVIOLET ABSORBENT COMPOSITION FUJIFILM CORPORATION (JP) 2011-08-04 US disclosed
US-20110163284-A1 LIGHTING UNIT COVER FUJIFILM CORPORATION (JP) 2011-07-07 US disclosed
US-20110163284-A1 LIGHTING UNIT COVER FUJIFILM CORPORATION (JP) 2011-07-07 US disclosed
US-20110092619-A1 FORMED RESIN ARTICLE AND POLYMER FILM FUJIFILM CORPORATION (JP) 2011-04-21 US disclosed
US-20110092619-A1 FORMED RESIN ARTICLE AND POLYMER FILM FUJIFILM CORPORATION (JP) 2011-04-21 US disclosed
US-7897761-B2 Heterocyclic compound FUJIFILM CORPORATION (JP) 2011-03-01 US disclosed
US-7897761-B2 Heterocyclic compound FUJIFILM CORPORATION (JP) 2011-03-01 US disclosed
US-20110024701-A1 Ultraviolet Absorbent Composition FUJIFILM CORPORATION (JP) 2011-02-03 US disclosed
US-20110024701-A1 Ultraviolet Absorbent Composition FUJIFILM CORPORATION (JP) 2011-02-03 US disclosed
US-20100004439-A1 Heterocyclic Compound FUJIFLM CORPORATION (JP) 2010-01-07 US disclosed
US-20100004439-A1 Heterocyclic Compound FUJIFLM CORPORATION (JP) 2010-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004439-A1 Heterocyclic Compound PTGER1, CYP1A1, ALOX12 ALDH1A1 1205/4885F2 56/4885SMN1; SMN2 4518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.